106 related articles for article (PubMed ID: 24968917)
1. Cross-sectional seroprevalence of antibodies against 6, 11, 16 and 18 human papilloma virus (HPV) types among teenagers and young women in Italy.
Lupi S; Bergamini M; Guidi E; Gregorio P;
Ann Ist Super Sanita; 2014; 50(2):171-7. PubMed ID: 24968917
[TBL] [Abstract][Full Text] [Related]
2. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of human papillomavirus antibodies in males and females in England.
Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, Brazil.
Rama CH; Villa LL; Pagliusi S; Andreoli MA; Costa MC; Thomann P; Longatto-Filho A; Eluf-Neto J
Int J Gynecol Cancer; 2010 Nov; 20(8):1405-10. PubMed ID: 21051985
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of IgG Antibodies against Human Papillomavirus (HPV) type 6, 11, 16, and 18 Virus-Like Particles in Women of Childbearing Age in Port Harcourt, Nigeria.
Okonko IO; Ofoedu V
J Immunoassay Immunochem; 2015; 36(6):622-38. PubMed ID: 25774633
[TBL] [Abstract][Full Text] [Related]
11. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran.
Aghakhani A; Mamishi S; Sabeti S; Bidari-Zerehpoosh F; Banifazl M; Bavand A; Ramezani A
Med Microbiol Immunol; 2017 Apr; 206(2):105-110. PubMed ID: 27858157
[TBL] [Abstract][Full Text] [Related]
12. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
Vos RA; Pasmans H; Tymchenko L; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; de Melker HE; van der Klis FRM
Vaccine; 2020 Mar; 38(13):2816-2826. PubMed ID: 32088019
[TBL] [Abstract][Full Text] [Related]
13. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.
Introcaso CE; Dunne EF; Hariri S; Panicker G; Unger ER; Markowitz LE
Sex Transm Infect; 2014 Sep; 90(6):505-8. PubMed ID: 24748563
[TBL] [Abstract][Full Text] [Related]
14. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
Husaiyin S; Han L; Mamat H; Husaiyin K; Wang L; Niyazi M
Jpn J Infect Dis; 2016 Jul; 69(4):273-8. PubMed ID: 26255734
[TBL] [Abstract][Full Text] [Related]
15. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
[TBL] [Abstract][Full Text] [Related]
16. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
18. Brief report: Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence among males and females entering military service during 2011-2012.
Clark LL; Rohrbeck P; Hurt L
MSMR; 2016 Jan; 23(1):14-5. PubMed ID: 26930144
[No Abstract] [Full Text] [Related]
19. Seroprevalence of seven high-risk HPV types in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; de Melker HE; Meijer CJ; Berbers GA; van der Klis FR
Vaccine; 2012 Oct; 30(47):6686-93. PubMed ID: 22959981
[TBL] [Abstract][Full Text] [Related]
20. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia.
Bedoya AM; Gaviria AM; Baena A; Borrero M; Duarte DF; Combita AL; Castaño J; Grisales H; Sánchez GI
Int J Gynecol Cancer; 2012 Feb; 22(2):303-10. PubMed ID: 22228426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
